Kuros Biosciences AG (LON:0RHR)

Market Cap	708.02M -29.9%
Revenue (ttm)	131.85M +54.9%
Net Income	6.76M
EPS	0.16
Shares Out	n/a
PE Ratio	111.16
Forward PE	84.81
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,694
Open	20.48
Previous Close	20.16
Day's Range	19.52 - 20.48
52-Week Range	16.46 - 32.48
Beta	0.73
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 3, 2027

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone graft...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 213
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RHR

Financial Performance

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error